Clinical trial
Aripiprazole Treatment of Prodromal Patients
NCT00237874 · Yale University, Other · Completed
Key facts
| NCT number | NCT00237874 |
|---|---|
| Title | Aripiprazole Treatment of Prodromal Patients |
| Official title | Aripiprazole Treatment of Prodromal Patients |
| Lead sponsor | Yale University, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychosis |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 15 |
| Start date | Feb 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: